课题基金 / 基金详情

MOLECULAR MECHIANISM OF RETINAL GANGLION CELL APOTPTOSIS ANDEXPERIMENTAL GENE THERAPRYTO PREVENT THE CELL DEATH

MOLECULAR MECHIANISM OF RETINAL GANGLION CELL APOTPTOSIS ANDEXPERIMENTAL GENE THERAPRYTO PREVENT THE CELL DEATH
视网膜神经节细胞凋亡的分子机制及预防细胞死亡的实验基因治疗
批准号:
10470361
负责人:
YOSHIMURA Nagahisa
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

YOSHIMURA Nagahisa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1) Research on rat retinal cell death following ischemia-reperfusionWE have shown that caspase-3 plays an important role in the inner retina, whereas caspase-1 was more important in the outer retina.Horizontal cells that express p16INK4 did not show apoptotic features but were necrotic but amacrine cells that do not express the gene were apoptotic.Reactive oxygen species played an important role in retinal ischemia-reperfusion injury.(2) Research on retinal ganglion cell apoptosisRetinal ganglion cells dying by apoptosis expressed c-jun and such cell also expressed caspase-2. Caspases-1 and -3 were not expressed dying retinal ganlion cells. BDNF treatment decreased the number of apoptotic cells but expression of c-jun was not different from without the treatment. Caspase-2 expression was decreased by the treatment.(3) Experimental gene therapy for RCS ratsTreatment of RCS rats with AAV-Bcl-xL was effective to reduce the visual cell damage found in the RCS rats.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
Shibuki H,Katai N,Kuroiwa S,Kurokawa T,Yodoi J,and Yoshimura N.: "Protective effect of adult T cell leukemia-derived factor on retinal ischemia-reperfusion injury in the rat."Invest Ophthalmol Vis Sci.. 39. 1470-1477 (1998)
Shibuki H、Katai N、Kuroiwa S、Kurokawa T、Yodoi J 和 Yoshimura N.:“成人 T 细胞白血病衍生因子对大鼠视网膜缺血再灌注损伤的保护作用。”Invest Ophasemol Vis Sci.. 39。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shibuki H,Katai N,Yodoi J,Uchida K,and Yoshimura N.: "Lipid peoxidation and peroxynitrite in retinal ischema-reperfusion injury."Invest Ophthalmol Vis Sci. 41. 3607-3614 (2000)
Shibuki H、Katai N、Yodoi J、Uchida K 和 Yoshimura N.:“视网膜缺血再灌注损伤中的脂质过氧化和过氧亚硝酸盐。”Invest Ophasemol Vis Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuroiwa S,Katai N,Shibuki H,Yoshimura N. et al.: "Expression of cell cycle-related genes in dying cells following retinal ischemic injury in the rat."Invest Ophthalmol Vis Sci.. 39. 610-617 (1998)
Kuroiwa S,Katai N,Shibuki H,Yoshimura N.等人:“大鼠视网膜缺血性损伤后死亡细胞中细胞周期相关基因的表达。”Invest Ophasemol Vis Sci.. 39. 610-617 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuroiwa S, Yoshimura N et al: "Apoptosis and necrisis in retinal ischemic reperfusion injury"Invest Ophthalmol Vis Sci. 40. 528-533 (1999)
Kuroiwa S、Yoshimura N 等人:“视网膜缺血再灌注损伤中的细胞凋亡和坏死”Invest Ophasemol Vis Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Development of the Method to Predict Efficacy of Anti-Vascular Endothelial Growth Factor Therapy for Exudative Age-Related Macular Degeneration Using Nuclear Magnetic Resonance
    • 批准号:
      26670753
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      YOSHIMURA Nagahisa
    • 依托单位:
    Development of neuroprotective treatment for incurable ocular diseases
    • 批准号:
      24249082
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.29万
    • 财政年份:
      2012
    • 负责人:
      YOSHIMURA Nagahisa
    • 依托单位:
    Personalized medicine for age-related macular degeneration
    • 批准号:
      21249084
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.79万
    • 财政年份:
      2009
    • 负责人:
      YOSHIMURA Nagahisa
    • 依托单位:
    Investigation of the mechanism of age-related macular degeneration in Japanese patients through genomic analysis and stem cell biology
    • 批准号:
      19390442
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2007
    • 负责人:
      YOSHIMURA Nagahisa
    • 依托单位:
    国内基金
    海外基金
    炎性反应中巨噬细胞激活诱导死亡(activation-induced cell death,AICD)的机理研究
    • 批准号:
      30330260
    • 项目类别:
      重点项目
    • 资助金额:
      105.0万元
    • 批准年份:
      2003
    • 负责人:
      顾军
    • 依托单位: